|
Tuesday, June 2, 2026
How to get past a running slump
New ‘Dark Energy’ Could Replace Oil
Dear Reader,
For years, we've been told SpaceX is a rocket company... that will one day take humans to Mars (and the moon).
But according to new satellite images from 300 miles above the Earth's surface, there is something very strange going on at SpaceX right now that has nothing to do with space.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
A new division of SpaceX is deploying a new way to power our world... that could replace our need for foreign oil forever -- without using nuclear fission, solar, wind, geothermal, coal, or any sort of battery.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
When you consider SpaceX burns 29,600 gallons of fuel per launch... it makes sense the business would want a better way to generate energy.
But what it’s doing right now could change not only SpaceX's operations... but also dramatically affect the entire country -- and your investments.
What it’s deploying is a newly permitted technology I know simply as "Dark Energy."
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
Most people have no idea something like this is even possible.
And it will sound like science fiction - at first.
But as I prove in my new free report, this is the beginning of what could be a $10 trillion boom for folks who know what to do - and who take the right steps now.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
SpaceX can't make this "Dark Energy" by itself. It relies on a small group of little-known suppliers to make it happen.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
And I believe that's why a laundry list of billionaires and tech CEOs are getting themselves into position.
Early supporters of "Dark Energy" technology include Nvidia CEO Jensen Huang, Oracle founder Larry Ellison, and OpenAI CEO Sam Altman.
Not to mention names like Brad Gerstner, a legendary tech investor who managed to be early on Uber, Microsoft, Amazon, Meta, and Nvidia.
He just joined a $300 million round backing this technology.
Or Garry Tan.
Garry invested in Coinbase back in 2012... turning a $300,000 stake into $2.4 billion in less than 10 years.
He has backed Airbnb, Stripe, DoorDash, and Dropbox... and his firm has invested in companies that are now worth more than $1 trillion combined.
Today, he's backing "Dark Energy" technology.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
This discovery could change our daily lives... and radically lower the cost of power.
And I believe that for you, this could be one the most profitable moments of your financial life if you position your money behind the right stocks before this news spreads.
I'm sharing all the details right now, on camera.
Click here to learn about this new "Dark Energy" for free.
Clicking the link above will opt you into communication from Altimetry, including the Altimetry Daily Authority daily E-letter. (Privacy Policy)
Regards,
Joel Litman
Chief Investment Officer, Altimetry
This ad is sent on behalf of Altimetry, 110 Cambridge Street, Cambridge, MA 02141.
Insider Buying Says Upstart Isn’t Down for the Count
Authored by Thomas Hughes. Originally Published: 5/18/2026.
Key Points
- Upstart insiders own a considerable exposure and are buying shares in May.
- Numerous catalysts exist to accelerate growth and profitability.
- Near-term headwinds exist, but analysts and institutions are buying into the long-term forecast.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Insiders are buying Upstart (NASDAQ: UPST), and the activity highlights two notable developments. The first is the kind of CEO transition investors can usually only hope for: a move from one founder to the next, preserving continuity of vision, and from one generation to the next, supporting long-term stability.
The second takeaway is that these insiders, including the outgoing and newly seated CEO, bought shares in May, even though they did not need to, given their already substantial exposure to this fintech stock.
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.
See the 5 stocks to avoidUpstart is an AI-powered lending platform. It is not a financial institution in the traditional sense, but rather a loan originator that uses a cloud-based, AI-enabled platform to qualify consumers and connect them with loans. The platform offers numerous benefits to the industry and consumers, including higher approval rates, lower risk, more efficient operations, 90% of loans being fully automated, and lower-cost loans for borrowers.
Analysts and Institutions Buy Into Upstart’s Long-Term Outlook
Analysts and institutional trends underscore the opportunity highlighted by the insiders. InsiderTrades tracks 16 analysts who rate the stock a consensus Hold. However, that cautious rating is offset by a 44% buy-side bias and the potential for 55% upside at the consensus target.
The bad news is that consensus has declined over the trailing 12 months, which helps explain the stock’s muted price action. Still, recent revisions suggest the trend may be stabilizing. Changes released since the May 5, 2026, earnings report include some price target reductions and initiations, but both remain near the consensus level, implying approximately 55% upside.
Institutional trends reveal a solid support base that has accumulated shares since the IPO. Key details include a 63% ownership rate, activity that ramped in 2025 and again in early 2026, and the overall balance of buying versus selling. Institutions are accumulating at a pace greater than $2-to-$1 and provide a strong market tailwind. The price action would be more bullish if not for the robust short interest.
Short sellers have leaned into this market because of its exposure to interest rates, arguing that its untested algorithm leaves it vulnerable. On the other hand, elevated short interest at 33% also sets the stock up for potential short squeezes if positive catalysts emerge, many of which are still ahead. The primary catalyst this year was securing more than $4 billion in committed capital. The deal, which includes Fortress and Centerbridge, derisks the outlook by reducing exposure to spot market rates and their impact on margins. Expansion into new verticals is also expected to drive growth, as is the move toward bank status.
Upstart: A Rising Start in Fintech
Earlier this year, Upstart announced that it had applied for a National Bank Charter. Still under review, the charter would enable Upstart to hold deposits, gain easier access to capital, and establish a more stable lending rate schedule. The impact on the business could be substantial, reducing risk, accelerating growth, and stabilizing the profitability outlook while effectively bypassing 50 individual state regulators in favor of federal oversight.
The price action suggests a potential bottom, but there is still no clear sign of a reversal. Support appears to be near $26.35 and may be difficult to break. The bad news is that this market may continue to hover around current levels until a stronger catalyst emerges. For now, the company is growing and outperforming consensus estimates, but profitability remains erratic and fell short in the latest report.
Upstart: Hurdles Versus Catalysts in 2026
Upstart’s biggest hurdle may be itself. The company’s AI models are effective, but class-action lawsuits allege they are also responsible for the company’s business weakness. Lawsuits filed in early 2026 claim the Model 22 upgrade was overly sensitive to macroeconomic signals, leading to significant declines in approvals, revenue, and earnings. The risk for investors is twofold: the risk of change and the risk of no change to the models.
Other risks include competition. While Upstart continues to gain traction, competitors including SoFi Technologies (NASDAQ: SOFI) and Affirm (NASDAQ: AFRM) continue to dominate the field. Their strengths lie in consumer loans, which affects Upstart’s addressable market, with Affirm’s point-of-sale model capturing share before consumers even need a loan. Upstart’s advantages include higher approval rates and turnkey integrations.
What is the market getting wrong about Upstart? The main miss is that Upstart is not just another cyclically exposed fintech with interest rate risk, but a scalable AI platform. While near-term hurdles remain, the long-term outlook includes rapid expansion into new verticals, including HELOCs and auto lending. Additionally, the 2026 margin compression appears to be driven largely by timing issues rather than fundamental defects, along with front-loaded reinvestment into growth verticals. The likely outcome is that the company continues to grow robustly in the coming years, refining its algorithm as it accelerates both growth and profitability.
Investors Abandoned These 3 AI Stocks Too Early, Says Jeff Clark
Authored by Bridget Bennett. Originally Published: 5/21/2026.
Key Points
- Jeff Clark of TradeSmith argues that narrow market breadth signals an approaching rotation away from AI and semiconductor stocks.
- Clark identifies Figma, Kratos Defense, and SoundHound AI as three pullback candidates trading well below their recent peaks despite solid fundamentals.
- Each stock has retreated sharply from highs while reporting revenue growth, making them potential beneficiaries if market leadership broadens.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
The headlines belong to AI and semiconductors right now. Chips are soaring, data center buildout stocks are making new highs, and the momentum crowd is firmly in control. But beneath the surface of a market that looks healthy, something odd is happening. The new-low list has been outrunning the new-high list even as the S&P 500 pushes above 7,500. That is not a healthy market. It is a narrow one.
Jeff Clark of TradeSmith has seen this setup before. His view is that when gains are concentrated in a thin slice of the market, the rotation trade is coming. And when it does, the money that rushes out of the hot names has to land somewhere. He thinks it lands in stocks that have already been left behind—and he has three specific names in mind.
The Setup: When Enthusiasm Gets Discounted to Infinity
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.
See the 5 stocks to avoidThe bull case for AI stocks is not fiction. Real money is flowing into data centers, chips, and infrastructure. The question Clark is asking is a different one: for how long? Once a data center is built, you do not build another one next door. Memory chips are a cyclical commodity—yet the market has priced them as if the cycle has been suspended permanently. Clark’s view is that the market is extrapolating today’s spending to infinity, and that a correction is overdue. That does not mean the AI trade is over. It means the easy money in the hot names may already be made, and the opportunity is now sitting in the stocks no one is talking about.
Figma: A Software Survivor Priced Like a Casualty
Figma (NYSE: FIG) went public at $33 a share, shot to more than $140, and has since retraced nearly all of those gains—spending time near $20 before a recent earnings pop pushed it back above $22. The surface-level read is that software is under pressure from AI, and Figma is getting caught in that tide. Clark’s read is almost the opposite.
Figma is not being destroyed by AI. It is integrating it. The platform, used by designers and product teams to build digital products and prototypes, has leaned into AI tooling rather than ignoring it, and the results are showing up in the numbers. The company’s user base is growing more than 50% year over year, and its most recent earnings report came in at 10 cents per share against an expected loss of 17 cents. Net dollar retention has climbed to 139%, meaning existing customers are spending more. Revenue growth is accelerating, not slowing.
For Clark, the thesis is simple: the stock was never worth $140, but it was also never worth being abandoned. Near $20, it is pricing in too much fear and not enough of what the business is actually doing. His target entry is around that level, and he sees it as a name worth holding for the long run.
Kratos Defense: A Drone Pure-Play That Got Ahead of Itself
The defense budget expansion story is real, and Kratos Defense & Security Solutions (NASDAQ: KTOS) sits right at the center of it. The company’s unmanned aerial systems—jet-powered drones, hypersonic vehicles, and related defense technology—have the Department of Defense as their primary customer, and that customer is spending aggressively. Kratos reported 22.6% revenue growth in its most recent quarter, with a record backlog and raised full-year guidance.
But the stock ran from roughly $35 a year ago to $120 at its peak, and then gave most of it back. It is trading near $53 today, which Clark acknowledges is not cheap on traditional metrics. This is not a value stock in the Graham-and-Dodd sense. What it is, he argues, is a growth stock with earnings expanding north of 45% annually, trading at a steep discount to where market enthusiasm put it just a few months ago.
Clark’s preferred entry is closer to $45 to $50. The defense sector as a whole has pulled back from early-2026 highs as investors wait for the spending surge to show up more aggressively in earnings. Clark sees that patience as the setup. Drone technology spending is not going away, and the pullback creates a better entry than anything available when KTOS was making headlines at the top.
SoundHound AI: Round-Trip Ticket, Better Destination
SoundHound AI (NASDAQ: SOUN) has put investors through a full round trip. A year ago, the stock was trading near $8, ran all the way to the low $20s on AI enthusiasm, and has since come back down to roughly $8. Anyone who bought near the top knows exactly how painful that ride has been.
But Clark’s focus is not on where the stock has been; it is on whether this entry price makes sense relative to what the company is building.
SoundHound’s technology is the conversational AI voice layer embedded in cars, restaurant kiosks, and consumer devices—the software that responds when a driver asks for the nearest gas station or a customer places a voice order. The company is not yet profitable. What it is, Clark says, is doing the right things operationally: growing revenue, expanding into new verticals, and positioning itself as the leading pure-play on voice AI at a price point that reflects none of that potential. At $8, the stock is trading where it was before the original wave of AI enthusiasm, and the business is meaningfully larger now than it was then.
The risk is real, as profitability is still quarters away at minimum, and the stock has shown it can be volatile in both directions. But for investors who believe voice AI will become embedded infrastructure, Clark’s argument is that the round trip back to $8 is exactly the kind of entry point that “buy low, sell high” was invented for.
The Bigger Picture
The three names share a common thread: each ran hard on genuine enthusiasm, pulled back further than the fundamentals justify, and now sits in the uncomfortable zone where patience is required. That discomfort is the point. The stocks generating today’s headlines are priced for perfection. These are not—and for investors willing to wait for the rotation Clark sees coming, that gap may be exactly where the opportunity lives.
This email is a sponsored email for Altimetry, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you need assistance with your account, please contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl. #620, Sioux Falls, S.D. 57103. U.S.A..
Most Lithium Supply Is Years Away. This Isn't.
Lithium Supply Takes Years. This Company Isn't Waiting
Most lithium supply still lives in the future.
New projects, new builds, long timelines - 7 to 10 years in many cases. That's the part the market understands.
Demand is moving faster.
EVs, AI, storage - all pulling on the same materials at once. The projections keep getting revised higher, and the gap is starting to show.
That gap creates urgency.
And urgency rewards the companies that move first.
This one did.
Instead of waiting on new supply, it found a way to produce lithium from a source the market largely overlooked - working inside a system that's been running for years, right here in the U.S.
No long buildout. No waiting on new infrastructure.
Just production.
It's early.
But it's already happening.
Qualcomm's TikTok AI Chip Deal Rewrites the Rules
Author: Jeffrey Neal Johnson. Originally Published: 5/27/2026.
Key Points
- Qualcomm secured a multi-million unit ASIC order from ByteDance, sending shares to an all-time high near $258 and driving a 60% advance over 30 days.
- Qualcomm's automotive revenue reached a record $1.3 billion in fiscal Q2 2026, up 38% year over year, with management targeting a $6 billion annualized run rate.
- Geopolitical export control risks and notable insider selling, including nearly $2 million in shares liquidated by Representative Sara Jacobs, present meaningful risks alongside the rally.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
For investors looking to capitalize on the structural transformation underway in artificial intelligence (AI) infrastructure, Qualcomm Incorporated (NASDAQ: QCOM) should now be a primary focus following a sudden shift in market dynamics.
A significant disruption has hit the semiconductor sector: Qualcomm recently landed a multi-million-unit order from ByteDance to provide custom Application-Specific Integrated Circuits (ASICs) for the tech giant's AI data centers.
The #1 stock to buy BEFORE the June 12th filing (Ad)
When the SpaceX IPO launches, most retail investors will be locked out. The banks, funds, and insiders get in early - while everyone else waits on the sidelines.
But one small infrastructure supplier - a critical piece Musk can't scale the Colossus network without - is still trading well under institutional radar. A new briefing reveals the name and ticker at no cost.
Get the SpaceX infrastructure stock name and ticker hereThe market reacted decisively to the news, sending shares to a new intraday all-time high of around $258 and driving a 60% advance over the trailing 30 days. This rapid repricing reflects a broader realization on Wall Street: Qualcomm's days as a purely cyclical smartphone supplier are officially over. Backed by a $29.4 billion capital expenditure tailwind from ByteDance and accelerating automotive sector revenue, Qualcomm's fundamentals are now demanding a valuation re-rating to match its tier-one semiconductor peers.
Cracking the Code, Qualcomm's Data Center ASIC Pivot
For years, institutional money managers assigned Qualcomm a lower multiple because of its heavy reliance on the volatile smartphone cycle. The ByteDance contract decisively breaks that legacy narrative. ByteDance is aggressively scaling Doubao, its highly popular artificial intelligence chatbot, and recently expanded its infrastructure budget by 25% to nearly $29.4 billion. Rather than relying entirely on traditional graphics processing units, which are currently constrained by global supply chains, ByteDance chose Qualcomm's custom ASICs to handle complex inference workloads.
This transition validates a strategic move Qualcomm quietly initiated months ago. The company executed a $2.4 billion acquisition of U.K.-based Alphawave Semi, which established a dedicated data center division. That acquisition also secured a separate, multi-generation custom ASIC co-development agreement with a top-tier hyperscaler, with initial shipments planned for Q4 2026.
By winning the ByteDance contract, Qualcomm has successfully entered a highly lucrative sector previously dominated by a tight Broadcom (NASDAQ: AVGO) and Marvell (NASDAQ: MRVL) duopoly. The market now sees a tangible revenue ceiling for Qualcomm's ASIC deployment, underscoring the company's ability to deliver power-efficient alternative compute architectures at massive scale.
Cars and Compute—A Two-Pronged Profit Attack
While the data center pivot is grabbing headlines, a second high-growth vertical provides a stabilizing revenue floor. Qualcomm continues to expand its automotive footprint, recently deepening a strategic partnership with Stellantis (NYSE: STLA) to integrate the Snapdragon Digital Chassis across connected vehicle fleets.
The financial impact of this automotive expansion is already visible on the income statement. In the fiscal second quarter of 2026, automotive revenue reached a record $1.3 billion, representing 38% year-over-year growth. Management now targets a $6 billion annualized run-rate exit by fiscal year 2026 (FY2026). This consistent, high-margin revenue stream helps offset the legacy mobile headwinds, which saw a slight 3.5% revenue contraction in the most recent quarter.
Beyond top-line growth, Qualcomm's balance sheet continues to improve. While analysts cheered a non-GAAP earnings beat of $2.65 per share, GAAP earnings rose 173% to $6.88 per share. A $5.7 billion deferred tax asset valuation reversal drove that spike, materially strengthening near-term balance sheet health. This financial flexibility supports the active $20 billion share buyback program, representing nearly 14.5% of outstanding shares, and a recent dividend increase to 92 cents per share, bringing the yield to a steady 1.43%.
The Qualcomm Paradox: Insiders Sell While Bulls Charge
The sudden ASIC catalyst caught many institutional bears off guard, triggering a short squeeze. Short interest had recently peaked near $11.8 billion, representing approximately 4.6% of the outstanding float. As news of the ByteDance deal hit the wire, forced covering accelerated the upward price action, resulting in a 16.59% climb over five trading days. Options data corroborates this momentum, showing aggressive institutional call buying concentrated at the 230 and 235 strikes.
Strategic investors must still balance this structural optimism with localized risks. Corporate insiders are actively distributing shares into this rally. Recent Securities and Exchange Commission filings reveal that an executive vice president offloaded $529,750 in stock. At the same time, Representative Sara Jacobs, granddaughter of a Qualcomm co-founder, liquidated nearly $2 million in shares near record highs. Total insider ownership now sits at a marginal 0.05%, signaling a stark divergence between institutional accumulation and executive profit-taking.
Geopolitical variables also introduce execution risk. ByteDance operates under strict regulatory scrutiny, and U.S. semiconductor export controls could potentially bottleneck future ASIC deliveries to Chinese data centers. Investors tracking this trade should monitor trade policy shifts, as any tightening of export restrictions could directly affect the realization of that $29.4 billion capital expenditure tailwind.
The June Catalyst, Get Ready for Qualcomm's Next Act
Despite the 40% year-to-date return, valuation metrics suggest the stock remains compressed relative to its tier-one peers. Qualcomm trades at a forward price-to-earnings ratio of 29. While elevated compared with legacy smartphone hardware multiples, this valuation sits below the premium multiples assigned to pure-play artificial intelligence infrastructure leaders. Profitability metrics remain exceptionally robust, with a 42.11% return on equity and a healthy net margin of 22.31%.
Wall Street analysts are scrambling to update their financial models. Firms like Tigress Financial recently raised their price targets to $280, while Benchmark raised its target to $225. Yet the broader market may not fully price in the next major event. On June 24, Chief Executive Officer Cristiano Amon will take the stage for Investor Day 2026. Market participants expect management to unveil a consolidated data center and physical artificial intelligence roadmap. This event could provide a near-term trigger for further multiple expansion, giving institutional money managers the long-term visibility needed to justify a higher premium.
Investors monitoring the semiconductor space may want to keep a close eye on Qualcomm as the June 24 presentation approaches. The combination of an active $20 billion buyback program, accelerating automotive margins, and a proven ability to win massive infrastructure contracts creates a compelling setup. Those with a moderate risk tolerance may want to add the stock to their watchlist to see whether Qualcomm can successfully navigate geopolitical export risks while executing its ambitious ASIC deployment strategy.
Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Author: Chris Markoch. Originally Published: 5/23/2026.
Key Points
- Kiniksa raised revenue guidance after ARCALYST sales jumped 56% year-over-year.
- The company remains the only FDA-approved treatment provider for recurrent pericarditis.
- Investors are closely watching KPL-387 as a potential next-generation growth catalyst.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Biopharmaceutical stocks take time and patience. But when a company gets it right, investors can be rewarded, as they have with Kiniksa Pharmaceuticals (NASDAQ: KNSA). The stock is up more than 100% over the past year. Much of that gain came after the company’s strong Q1 earnings report on April 28, when it topped adjusted earnings per share (EPS) estimates by 9 cents, coming in at 27 cents.
At that time, the company also announced the launch of a targeted direct-to-consumer TV campaign for ARCALYST in recurrent pericarditis. ARCALYST is the first and only U.S. Food & Drug Administration (FDA) approved therapy for recurrent pericarditis, a designation it received in 2021.
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions.
See the 5 stocks to avoidAfter some initial volatility, ARCALYST generated revenue of about $48 million in March 2023. Revenue growth has since accelerated, reaching a record $214.27 million in Q1 2026, a 56% year-over-year (YOY) gain. The new campaign is important because it shows that Kiniksa is investing in demand generation at scale rather than relying solely on prescriber growth.
To that end, the company raised its full-year revenue guidance to $930 million to $945 million. The previous guidance called for a range between $900 million and $920 million.
A Singular Focus Moving Into Its Second Generation
Like many biotech companies, Kiniksa focuses on discovering and advancing novel, transformative therapies for patients with unmet medical needs. The company’s specific focus is on cardiovascular diseases, specifically pericarditis.
Pericarditis is an inflammation of the pericardium—the thin, fluid-filled sac surrounding the heart—that causes sharp chest pain, fatigue, and in severe cases, dangerous fluid buildup around the heart. When the condition keeps returning despite standard anti-inflammatory treatments like NSAIDs and colchicine, it becomes recurrent pericarditis, a chronic autoinflammatory disease driven by an overactive IL-1 immune response.
How big is this market? Approximately 40,000 patients in the U.S. seek and receive treatment for recurrent pericarditis each year, with roughly 14,000 of those experiencing two or more recurrences because of persistent underlying disease or an inadequate response to conventional therapies.
That 14,000 figure is roughly equal to Kiniksa’s initial target, of which 18% were on ARCALYST by the end of 2025. That leaves about 80% of the addressable market untreated, and, for now, Kiniksa has the field to itself as it works to keep competitors out.
That leads to the company’s pipeline, which includes its KPL-387 drug. This is a once-monthly subcutaneous self-injection that marks a significant upgrade over ARCALYST’s more frequent dosing. KPL-387, which is in Phase 2 trials, received FDA Orphan Drug Designation (ODD) in October 2025.
Among the many benefits of ODD is that Kiniksa will have exclusive marketing rights for seven years. Investors in the biotech space like exclusivity, and this is another opportunity for Kiniksa to deliver.
Valuation May Become a Concern
Biotechnology stocks can be volatile, and Kiniksa is no exception. However, unlike many speculative biotech names that are unprofitable and generate little to no revenue, Kiniksa has become a profitable company with revenue that is growing sequentially and YOY.
That said, KNSA now trades at around 60x earnings. That’s a significant premium to the S&P 500 (around 27x) and the broader biotech sector (around 17x). The bull case is that Kiniksa has earned this premium with an outlook for strong revenue growth and higher margins.
Skeptics could argue that the current stock price depends on flawless execution, which may or may not happen. However, waiting on the sidelines has not worked out well for investors so far, and the consensus price target of $60.86 still points to meaningful upside from current levels.
KNSA Chart Makes an Argument to Wait
The technical picture supports a measured approach for investors considering a position. After surging nearly 20% following the earnings report, KNSA has pulled back to the $53-$54 range on declining volume. This suggests a healthy consolidation, not a structural breakdown. The relative strength index (RSI) has retreated from overbought territory near 80 to a neutral 51, meaning the post-earnings momentum has been worked off without significant price damage. The MACD crossover, however, suggests modest near-term selling pressure may not be fully exhausted.
Investors looking for a more defined entry point may want to watch the 50-day simple moving average, currently tracking in the $47-$49 range. A successful test of that level—particularly if the MACD turns positive on the retest—would confirm the broader uptrend remains intact and offer a more favorable risk-reward setup ahead of the anticipated KPL-387 Phase 2 data in the second half of 2026.
This email is a paid sponsorship for i2i Marketing Group, LLC, a third-party advertiser of MarketBeat. Why did I receive this message?.
We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company's SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
If you have questions or concerns about your account, feel free to email our South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
Copyright 2006-2026 MarketBeat Media, LLC.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. United States..
2026 Gold Forecast: A Perfect Storm For Demand
Explore how gold can safeguard your wealth—download your exclusive 2026 forecast now! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏...
-
Having trouble viewing this email? View it as a Web page . You are subscribed to Constit...
-
Plus, Deaths of foreign fighters draw renewed attention to the military volunteers in Ukraine. ...
-
View Images Library Photos and Pictures. Как сделать усилитель сигнала сотовой связи своими руками Усилитель 3G сигнала своими руками Антен...
